Seed grants $75,000–$200,000: Donations Fund Clinical Trials at HCRF

October 4, 2026

Seed grants $75,000–$200,000: Donations Fund Clinical Trials at HCRF

Donations pay for the people, materials, and small trials that larger funders often pass over: the salaries, the patient support, the lab supplies, and the regulatory costs that turn a promising idea into early data. That early data is often what unlocks federal or industry funding later. Foundations like HCRF exist to channel those gifts directly into research that might otherwise never get a chance.

TL;DR:

• Donations fund early-stage cancer research costs, including personnel, patient support, lab supplies, manufacturing, data management, and regulatory fees.
• Typical pilot studies cost between $75,000 and $200,000, while Phase I trials often start around $150,000, with expenses growing based on manufacturing and monitoring needs.
• Recipient foundations vet proposals through transparency signals like IRS status, published policies, conflict disclosures, and impact reports to ensure trustworthy stewardship.
• Less than 10% of drugs entering clinical trials gain approval, mainly due to safety or efficacy issues, with philanthropy providing critical early data to attract larger funding.
• Smaller donor contributions support high-risk, unproven research stages, which are essential to breakthroughs, and should be directed to specific milestones with transparent updates.

Table of Contents

• What donation dollars actually pay for in a clinical trial
• Types of donations and practical ways to give
• How reputable nonprofits steward funds and choose projects
• Evidence of impact and the limits of donation-funded research
• HCRF in practice: turning donations into clinical research
• A donor’s role in moving research forward
• How to support HCRF now
• FAQ
• Sources

What donation dollars actually pay for in a clinical trial

A gift to cancer research rarely covers one thing. It covers a web of costs that together make a trial possible.

• Personnel: research nurses, data coordinators, and the scientists who design and run the study.
• Patient support: travel reimbursement, lodging, and sometimes lost-wage assistance so participants can stay enrolled.
• Lab supplies and reagents: the chemicals, assays, and equipment needed to test a hypothesis.
• GMP manufacturing: producing a drug candidate under the quality standards required for human testing.
• Data management: the systems that track safety signals and outcomes across every patient.
• IRB and regulatory fees: the ethics review and compliance costs required before a single patient is enrolled.

Pilot and observational studies often run in the $75,000 to $200,000 range, while a Phase I interventional trial commonly starts around $150,000 and climbs from there depending on manufacturing and monitoring needs, according to practical cost estimates compiled for major-gift donors. Early-stage, translational work rarely attracts industry money because it carries the highest risk of failure. That is precisely where philanthropy carries the most weight: it funds the unproven idea long enough to find out whether it deserves a bigger investment. For a fuller breakdown of how these costs scale by trial phase, see what cancer research really costs.

Types of donations and practical ways to give

Every gift has a shape, and the shape affects how quickly it can move into research.

1. One-time gifts: fast, flexible, and often used to close a funding gap on a specific project.
2. Recurring gifts: predictable income that lets a foundation plan multi-year research commitments.
3. Major gifts: large, often restricted contributions tied to a named study or piece of equipment.
4. Donor-advised funds: tax-efficient vehicles that let a donor recommend grants over time; see how a donor-advised fund can support cancer research.
5. Planned gifts: bequests or estate commitments that fund research long after the gift is made.
6. Events and sponsorships: galas and kickoff events that combine fundraising with donor engagement.
7. Crowdfunding and peer-to-peer campaigns: community-driven giving, often run through fundraising platforms built for campaigns.

Restricted gifts guarantee your money reaches a named project, but they can leave a foundation short on general operating funds. Unrestricted gifts give a research team flexibility to respond to an urgent discovery. Before giving, ask what the gift will fund, over what timeline, and whether you will receive a report once it closes.

How reputable nonprofits steward funds and choose projects

A well-run foundation acts as a knowledge broker, not just a collection plate. Scientific review committees and advisory boards vet proposals, rank them against strategic priorities, and steer dollars toward the research most likely to produce usable data.

Before directing a gift, look for these signals:

• Confirmed IRS 501©(3) status, which you can verify independently.
• Published bylaws and grant-making policy that explain how funding decisions are made.
• Conflict-of-interest disclosures for board members and reviewers.
• Publicly available budgets and impact reports showing where prior gifts went.

Transparency is what separates a trustworthy funder from one that simply asks for money, a distinction funder transparency guidance makes clear.

Pro Tip: Ask any foundation what specific milestone your gift will fund and when you can expect a progress update. If they cannot answer both, keep looking.

Evidence of impact and the limits of donation-funded research

Philanthropy’s fingerprints show up in real approvals. A bibliometric analysis found that nonprofit funding touched all 19 targeted breast-cancer therapies the FDA approved between 2012 and 2023, appearing at multiple points across each drug’s development, according to research on Susan G. Komen-funded breast cancer therapies. That same analysis noted Komen invested nearly $1.1 billion over the period studied.

Fewer than 10% of drugs that enter clinical trials are ultimately approved, a reminder of how high the attrition rate runs across the entire industry, according to peer-reviewed analysis of clinical development attrition.

• Most trial failures stem from safety or efficacy issues rather than funding.
• Donations often serve as critical early investments that generate preliminary data.
• This initial data frequently helps attract federal or industry funding for subsequent, larger phase trials.

HCRF in practice: turning donations into clinical research

A 501©(3) nonprofit organization partners with a leading cancer center to fund cancer research that traditional grant committees often pass over. That positioning, supporting out-of-the-box projects at a nationally recognized center, is central to how HCRF decides where gifts go.

HCRF channels donations into several program types:

• Seed grants that give investigators the preliminary data needed to compete for larger NIH or industry funding.
• Sponsored trials tied to specific research priorities at the Lurie Cancer Center.
• Diversity and access efforts, expanding who can participate in trials, detailed in HCRF’s work on clinical trial diversity.
• Donor reporting, so contributors can see what their gift supported.

Donors can take direct action: attend an event, sponsor a gala table, designate a gift to a specific research area, or simply request a progress report. Practical steps for each are outlined in how to donate to cancer research and drive real impact.

A donor’s role in moving research forward

Every donor who gives to cancer research is funding a risk that someone else wasn’t willing to take. That risk is where breakthroughs come from: the study too early for a federal grant, the hypothesis too unproven for industry, the patient who needs support just to stay enrolled. We believe giving works best when it is informed, not blind. Ask for the report. Ask what milestone your gift reached. Transparent stewardship is not a courtesy, it is the standard every donor deserves, and the standard we hold ourselves to.

— HCRF

How to support HCRF now

Supporting cancer research through a dedicated nonprofit means your gift supports projects often overlooked by larger funders, with reporting that shows you where it landed. That is the real difference between giving blindly and giving with purpose.

• Attend Cocktails for a Cure: a $150 per-person kickoff event supporting HCRF’s mission, with details at the event page.
• Sponsor or attend the 13th Annual Wings To Cure Gala: HCRF’s flagship fundraising event, with sponsorship information at the gala page.
• Give online or through a donor-advised fund: visit the Hippocratic Cancer Research Foundation to donate directly or direct a DAF grant.

Visit the Hippocratic Cancer Research Foundation to give today, designate your gift, or ask about upcoming events.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

FAQ

How to start a donation fund for cancer research?

Starting a donation fund usually means choosing a vehicle such as a donor-advised fund, a dedicated online giving page, or a recurring gift program, then naming the research priority you want it to support. Many donors begin by contacting an established foundation directly to discuss restricted versus unrestricted giving. See how to donate to cancer research and drive real impact for practical starting steps.

Why do most clinical trials fail to reach approval?

Clinical trials fail mostly due to safety concerns or insufficient evidence of efficacy in human testing, not funding alone. Fewer than 10% of drugs that enter clinical trials are ultimately approved for marketing, according to peer-reviewed attrition data, which is why early, donor-funded pilot data matters so much.

Are there research grants available for 2026?

Government funding bodies periodically open clinical trial award programs, such as the CDMRP’s Prostate Cancer Research Program, detailed in its FY26 award documentation. Many researchers use donor-funded seed grants first to generate the preliminary data these larger awards require.

How do donor contributions compare to government or industry funding?

Donor contributions are typically smaller than government or industry grants but far more flexible, often funding the earliest, riskiest stage of a project that larger funders will not touch yet. That early data frequently becomes the evidence needed to secure the next round of institutional or federal funding.

Recommended

• Early-Stage Research Funding for Donors & Lurie
• Sponsors and Sites: How HCRF Expands Clinical Trial Diversity
• Cancer Research Funding: A 2026 Donor’s Guide
• Breast Cancer Research Funding: A Researcher’s Guide